Filing Details

Accession Number:
0001140361-21-020090
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-07 17:25:44
Reporting Period:
2021-06-03
Accepted Time:
2021-06-07 17:25:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1755237 Cyclerion Therapeutics Inc. CYCN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478485 M Peter Hecht C/O Cyclerion Therapeutics, Inc.
245 First Street, 18Th Floor
Cambridge MA 02142
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-03 823,170 $3.28 2,047,698 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 485 Indirect The 2000 Trust for Alexis Mae Hecht
Common Stock 485 Indirect The 2000 Trust for Malcolm Paul Hecht
Common Stock 485 Indirect The 2000 Trust for Zoe Niovi Hecht
Footnotes
  1. On June 3, 2021, the reporting person agreed to purchase directly from the Issuer 823,170 shares of Common Stock of the Issuer in a private placement transaction.
  2. These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.